Media

Japan’s Rohto Pharmaceutical acquires 13% stake in SastaSundar

June 01, 2017   |   Published by Medianama.com  
Japanese based Rohto Pharmaceutical Co has acquired 13% stake in Kolkata based medicine delivery platform SastaSundar, reports Economic Times. The Japnese group paid $5 million for the stake. The company will use the funds to expand operations in Delhi and in 12 states across the country. The startup will also collaborate with the Rohto to expand operations, the report added.

Japanese Firm Invests $5 Million In Sastasundar Healthbuddy

June 01, 2017   |   Published by Livemint   |   http://epaper.livemint.com/epaper/iphone/homepage.aspx#_articlee8fb5bf2-527a-43c1-9df5-f59cdb0afbe6
Japanese Firm Invests $5 Million In Sastasundar Healthbuddy

SastaSundar Bags $5M

June 01, 2017   |   Published by Bwdisrupt   |   http://bwdisrupt.businessworld.in/article/ERP-Platform-Tripeur-Raises-Seed-Funding-Urban-Ladder-Appoints-Jaipal-Singal-as-Its-CFO-SastaSundar-Bags-5M-More/01-06-2017-119326/
Japan-based pharmaceutical company Rohto Pharmaceutical has invested $5 million (Rs 33.4 Cr) in online pharmacy SastaSundar Healthbuddy Limited.

Rohto Pharma Announces Capital And Business Alliance With SastaSundar.com

June 01, 2017   |   Published by Pharmabiz.com  
Rohto Pharmaceutical, Japan, announced a Capital and Business Alliance with SastaSundar Healthbuddy Limited, a wholly owned subsidiary of SastaSundar Ventures Limited, an NSE and BSE listed company, owning and operating SastaSundar.com, a leading digital network of healthcare in India. Rohto has invested $5 million (Rs. 32.2 crore) in SastaSundar Healthbuddy Limited and is likely to make further investments as the business progresses. Dr. Lekh Raj Juneja, executive vice-president & global head international business of Rohto, Mr. B. L. Mittal, founder & executive chairman, SastaSundar Healthbuddy Limited, His Excellency, Ryoji Noda (Consul General of Japan in Mumbai), Koji Suzuki, managing director, Rohto Pharma (India) Pvt Ltd. & Ravi Kant Sharma, managing director & chief executive officer, SastaSundar Healthbuddy Limited were present to announce this grand alliance. “Rohto is looking for the expansion of its base in India with SastaSundar.com as its preferred partner in the e-commerce business. SastaSundar.com has shown significant growth in a short span since starting their operations and we were indeed impressed with their business model and hence decided to invest. Rohto will assist SastaSundar.com in scaling its operations pan-India with our global expertise. Rohto embraces this entrepreneurial opportunity as the friendship between the two great nations of India and Japan. With this alliance, we will in our small ways contribute towards attaining the Hon’ble Prime Minister Of India, Narendra Modi’s vision of Make-in-India and Digital India initiative”, said Dr Lekh Raj Juneja, exective vice-president & global head international business of Rohto. “At SastaSundar.com, we use knowledge and digital connectivity to reduce cost and add convenience in making available high quality medicines, healthcare products and services through fast online access and convenient home delivery process to make life simple and happy. We are extremely proud to have Rohto joining hands with us, which will be mutually beneficial. As we are on a growth path and looking for a pan-India expansion, we plan to scale up our operations in Mumbai soon. Our association with Rohto will help us in achieving our immediate goal”, said BL Mittal, founder & executive chairman, SastaSundar Healthbuddy Limited. SastaSundar aims to have a total of 250 Healthbuddy stores in West Bengal & 50 Healthbuddy stores in Delhi by March 2018. “By utilising the network of SastaSundar we will be introducing well-acclaimed products from our global brands in the healthcare segment in India. This will also help us in expanding our footprints in India, which is a key emerging market for us”, added Dr Juneja. “Partnership of Rohto and SastaSundar.com will address one of the biggest problem of India - consistent access to affordable healthcare in a convenient manner”, added Mittal. Established in 1899, Rohto initially played a role in every customer’s welfare with its drugs including unique eye drops and gastrointestinal medicines. Later, the company successfully ventured into dermal medicines, skin care, and functional foods. Rohto, a global leader, selling and marketing its products in more than 120 countries, aspires to become a company that challenges itself for “healthy life span” through both advanced life science and daily lifestyle based on technological expertise.

Rohto Pharmaceutical Co., Ltd., Japan Forges a Capital & Business Alliance with SastaSundar.com

May 31, 2017   |   Published by orientpublication.com  
Mumbai, 31st May, 2017: Rohto Pharmaceutical Co., Ltd. (“Rohto”) Japan, today, announced a Capital and Business Alliance with SastaSundar Healthbuddy Limited, a wholly owned subsidiary of SastaSundar Ventures Limited, an NSE and BSE listed company, owning and operating SastaSundar.com, a leading digital network of healthcare in India. Rohto has invested $5 million (Rs 32.2 crores) in SastaSundar Healthbuddy Limited and is likely to make further investments as the business progresses. Dr. Lekh Raj Juneja, Executive Vice-President & Global Head International Business of Rohto, Mr. B. L. Mittal, Founder & Executive Chairman, SastaSundar Healthbuddy Limited, His Excellency, Mr. Ryoji Noda (Consul General of Japan in Mumbai), Mr. Koji Suzuki, Managing Director, Rohto Pharma (India) Pvt Ltd. & Mr. Ravi Kant Sharma, Managing Director & CEO, SastaSundar Healthbuddy Limited were present to announce this grand alliance. Established in 1899, Rohto initially played a role in every customer’s welfare with its drugs including unique eye drops and gastrointestinal medicines. Later, the company successfully ventured into dermal medicines, skin care, and functional foods. Rohto, a global leader, selling and marketing its products in more than 120 countries, aspires to become a company that challenges itself for “healthy life span” through both advanced life science and daily lifestyle based on technological expertise. Rohto entered India in 2010, by establishing its wholly-owned subsidiary ‘Rohto Pharma (India) Pvt. Ltd.’, with its leading lip care brand ‘LipIce’. The following year it launched a range of products including ‘LipIce Color’ under its brand ‘LipIce’. Subsequently, it launched two new brands – ‘OXY’ specialised skin care range for men, and ‘Acnes’ for specialised acne care, in India. SastaSundar.com is building India’s leading digital network of healthcare, managing efficient pharma & wellness products’ supply chain & connecting doctors, diagnostic services, healthcare clinics and health information services. Currently, SastaSundar.com is operating in West Bengal only and will expand to pan India. The digital network of SastaSundar.com is being built upon the online to offline model of healthcare delivery leveraging technology and inventory less service centre of the franchise called Healthbuddy. For the year ended March 2017, the GMV of SastaSundar.com was Rs.153 crores and it delivered close to 17 lacs orders. As on date, it has 178 Healthbuddy stores with 4.40 lacs registered customers. SastaSundar.com has portfolio of its own brand which includes unique line of customised health supplement called DNAVITA, authentic herbal products in the brand of Healthbuddy and toxin free beauty care - Zerotox. Apart from this product line, it has health information services through its channel “Know Health” which consists of Health Articles, Medicine Info and Substitute of Generic Medicines, Symptoms Checker and Health Tools. SastaSundar.com provides customised app using artificial intelligence and has unique service capability based upon health condition data. “Rohto is looking for the expansion of its base in India with SastaSundar.com as its preferred partner in the e-commerce business. SastaSundar.com has shown significant growth in a short span since starting their operations and we were indeed impressed with their business model and hence decided to invest. Rohto will assist SastaSundar.com in scaling its operations pan-India with our global expertise. Rohto embraces this entrepreneurial opportunity as the friendship between the two great nations of India and Japan. With this alliance, we will in our small ways contribute towards attaining the Hon’ble Prime Minister Of India, Mr Narendra Modi’s vision of Make-in-India and Digital India initiative”, said Dr Lekh Raj Juneja, Exective Vice-President & Global Head International Business of Rohto. “At SastaSundar.com, we use knowledge and digital connectivity to reduce cost and add convenience in making available high quality medicines, healthcare products and services through fast online access and convenient home delivery process to make life simple and happy. We are extremely proud to have Rohto joining hands with us, which will be mutually beneficial. As we are on a growth path and looking for a pan-India expansion, we plan to scale up our operations in Mumbai soon. Our association with Rohto will help us in achieving our immediate goal”, said Mr BL Mittal, Founder & Executive Chairman, SastaSundar Healthbuddy Limited. SastaSundar aims to have a total of 250 Healthbuddy stores in West Bengal & 50 Healthbuddy stores in Delhi by March 2018. “By utilising the network of SastaSundar we will be introducing well-acclaimed products fromour global brands in the healthcare segment in India. This will also help us in expanding our footprints in India, which is a key emerging market for us”, added Dr Juneja. “Partnership of Rohto and SastaSundar.com will address one of the biggest problem of India - consistent access to affordable healthcare in a convenient manner”, added Mr Mittal. India is one of the largest manufacturers of medicines in the world and boasts of the best of doctors. Yet, the majority of Indians do not have access to consistent and affordable healthcare. This is where the association between Rohto and SastaSundar will play a major role in connecting the missing link by leveraging digital technology.

Japanese Firm Rohto Pharma Plans To Expand Base In India

May 31, 2017   |   Published by Kodson.com  
Japanese firm Rohto Pharmaceutical Co plans to expand its base in India with SastaSundar Healthbuddy Ltd as its preferred partner.(sastasundar.com) Japanese firm Rohto Pharmaceutical Co plans to expand its base in India with SastaSundar Healthbuddy Ltd as its preferred partner. “We are looking for expansion of our base in India with SastaSundar as our preferred partner. We have invested USD 5 million (Rs 32 crore) to acquire 13 per cent stake in SastaSundar ,” Rohto Executive VP and Global Head of International Business Lekh Raj Juneja told reporters here. By utilising the network of SastaSundar, Rohto will be expanding its presence in India, which is a key emerging market for the company, Juneja said. Rohto is open to further investments in the Indian firm, Juneja said, without specifying any amount. Established in 1899, Rohto makes and markets pharma products, cosmetics and functional foods. It has set up wholly owned subsidiary Rohto Pharma (India) in 2010 and launched brands like Lipice, OXY and Acnes in the domestic market. SastaSundar, which owns and operates digital helathcare network SastaSundar.com, currently operates only in West Bengal and is looking at pan-India expansion. The company, which operates through franchise model, aims to have 250 Heathbuddy stores in West Bengal and 50 stores in Delhi by March 2018. “At SastaSundar, we use knowledge and digital connectivity to reduce cost and add convenience in making available high quality medicines, healthcare products and services through fast online access and convenient home delivery process to make life simple. “We are on a growth path and looking for a pan-India expansion. We plan to scale up our operations in Mumbai soon. Our association with Rohto will help us in achieving our immediate goal,” SastaSundar executive chairman B L Mittal said.

Rohto Pharmaceutical which is a Japanese firm, has been planning to expand its base in India with SastaSundar Heathbuddy

May 31, 2017   |   Published by Equitypandit  
Rohto Pharmaceutical which is a Japanese firm, has been planning to expand its base in India with SastaSundar Heathbuddy Ltd as its preferred partner. Raj Juneja, Rohto Executive VP and Global Head of International Business said that “We are looking for expansion of our base in India with SastaSundar as our preferred partner. We have invested USD 5 million (Rs 32 crore) to acquire 13 percent stake in SastaSundar.” He further said that, Rohto will be able to expand its presence in India utilising the network of SastaSundar.

Japan Based Rohto Pharmaceutical invests USD 5 MN in SastaSundar Healthbuddy

May 31, 2017   |   Published by Knowstartup.com   |   http://knowstartup.com/2017/05/sastasundar-funding/
Japan-based pharmaceutical company Rohto Pharmaceutical has invested USD 5 Mn in online pharmacy SastaSundar Healthbuddy Limited.

Announcement of Capital and Business Alliance Agreement with Sasta Sundar Healthbuddy Limited

May 31, 2017   |   Published by Kabukei.jp   |   http://kabukei.jp/posts/5446547
Roto Pharmaceutical: Announcement of Capital and Business Alliance Agreement with Sasta Sundar Healthbuddy Limited in India

Japanese Firm Rohto Pharma Plans To Expand Base In India

May 31, 2017   |   Published by TheFirstMail.in  
Japanese firm Rohto Pharmaceutical Co plans to expand its base in India with SastaSundar Healthbuddy Ltd as its preferred partner. "We are looking for expansion of our base in India with SastaSundar as our preferred partner. We have invested USD 5 million (Rs 32 crore) to acquire 13 per cent stake in SastaSundar ," Rohto Executive VP and Global Head of International Business Lekh Raj Juneja told reporters here. By utilising the network of SastaSundar, Rohto will be expanding its presence in India, which is a key emerging market for the company, Juneja said. Rohto is open to further investments in the Indian firm, Juneja said, without specifying any amount. Established in 1899, Rohto makes and markets pharma products, cosmetics and functional foods. It has set up wholly owned subsidiary Rohto Pharma (India) in 2010 and launched brands like Lipice, OXY and Acnes in the domestic market. SastaSundar, which owns and operates digital helathcare network SastaSundar.com, currently operates only in West Bengal and is looking at pan-India expansion. The company, which operates through franchise model, aims to have 250 Heathbuddy stores in West Bengal and 50 stores in Delhi by March 2018. "At SastaSundar, we use knowledge and digital connectivity to reduce cost and add convenience in making available high quality medicines, healthcare products and services through fast online access and convenient home delivery process to make life simple. "We are on a growth path and looking for a pan-India expansion. We plan to scale up our operations in Mumbai soon. Our association with Rohto will help us in achieving our immediate goal," SastaSundar executive chairman B L Mittal said.


Customer Care
Connecting ...
SastaSundar
Chat Now